Document is current
Any future updates will be listed below
-
Authors
Galán-Martín, Miguel A.
Montero-Cuadrado, Federico
Lluch-Girbes, Enrique
Coca-López, M. Carmen
Mayo-Iscar, Agustín
Cuesta-Vargas, Antonio http://orcid.org/0000-0002-8880-4315
-
Funding
Funding for this research was provided by:
GRS (121b16)
Spanish Ministry of Economy and Competitiveness,ortations du Québec (MTM2017-86061-C2-1-P)
Education Department of Castilla and León Government and FEDER, (VA005P17 and VA002G18)
- License Information
-
More Information
Article History
Received: 6 August 2019
Accepted: 10 October 2019
First Online: 3 November 2019
Ethics approval and consent to participate
: This study has been approved by the Ethics and Clinical Research Committee in the East Valladolid health area (CASVE-NM_16–252), and by the Ethics and Clinical Investigation Committee in the West Valladolid health area (CEIC:26/17), and shall be carried out in accordance with the Declaration of Helsinki. The informed consent material is available in Spanish with the approved protocol. The informed consent obtained was written. Adverse effects from the treatment are not expected to occur, but if they do, all patients will be covered by the Public Health System.
: Written consent was received from all participants to publicly share the results of the study.
: The authors declare that they have no competing interests.
